Neuromodulation is not a new concept, but companies continue to innovate in that space to help deliver better outcomes to patients. One of those companies is Saluda Medical, which was founded in Australia but has since established a presence in Minnesota. On this week's Medical Alley Podcast, Saluda President and CEO Jim Schuermann joins to share more about the company's technology, which is able to sense the body's response to stimulation. He shares more about the clinical research Saluda has put into its product, discusses how artificial intelligence could play a role in neurostimulation, and much more.
Follow Medical Alley on social media on LinkedIn, Facebook, Twitter and Instagram.